UNSPSC 85592422: Replacement of esophagus with nonautologous tissue substitute, via natural or artificial opening

This classification denotes the group of activities that yields a surgical intervention or procedure to replacement of esophagus with nonautologous tissue substitute, via natural or artificial opening. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0DR57KZ

UNSPSC 85592422 Replacement of esophagus with nonautologous tissue substitute, via natural or artificial opening is a Commodity code that shows little relevant recent activity aligned with its nominal scope. The recent state and local opportunities posted under this code span independent medical evaluation services for pension disability determinations, surgical benefit carve-out networks, occupational medical surveillance, emergency and specialty medical care for detained youth, pharmacy benefit management, and temporary health professional staffing — none of which involve esophageal replacement procedures or implantable tissue substitutes. The mismatch between the code's clinical product name and the actual procurement activity suggests either systematic coding drift or data classification errors in the underlying state and local opportunity feeds.

The issuing bodies include city retirement offices (City of Phoenix), county health systems and probation departments (Harris County, Santa Clara County, Collier County), a state transportation agency (Washington State Department of Transportation), and municipalities (City of Long Beach). Geographic representation spans Arizona, California, Florida, Texas, and Washington. No opportunities directly procure esophageal substitutes, surgical implants, or related medical devices or procedural services that would align with the code's product description. Given the absence of relevant recent solicitations, this code does not present actionable procurement activity for vendors in medical device, tissue substitute, or esophageal reconstruction markets.